Skip to main content

PGT-M conditions

This table shows all PGT-M conditions currently approved and awaiting consideration by the HFEA.

Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact pgtm@hfea.gov.uk.

Download full approved condition list.

Condition name Status OMIM number Documents
Spondyloepimetaphyseal dysplasia, Strudwick approved 184250
Spondyloepiphyseal Dysplasia Congenita approved 183900
Spondyloepiphyseal dysplasia tarda, X-linked (SEDT) approved 313400
Spondyloepiphyseal Dysplasia with Congenital Joint Dislocations (SEDCJD) approved 143095
Spondylo-epiphyseal dysplasia, Maroteaux type approved 184095
Spondylometaepiphyseal Dysplasia Short Limb Hand type (SMED-SL) approved 271665
Spondylometaphyseal dysplasia, Kozlowski type (SMDK) approved 184252
Stargardt disease type 1 approved 248200
Stickler Syndrome Type I, II, III and IV approved 108300, 609508, 604841, 184840, 614134
Stuve-Wiedemann Syndrome (Schwartz-Jampel Type 2 syndrome) approved 601559
Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD) approved 271980
Sudden Cardiac Failure, Alcohol Induced (SCFAI) approved 617223
Sudden Cardiac Failure, Infantile (SCFI) approved 617222
Surfactant Metabolism Dysfunction, Pulmonary Type 1 (SMDP1) approved 265120
Surfactant Metabolism Dysfunction, Pulmonary Type 3 (SMDP3) approved 610921
Surfactant Metabolism Dysfunction, Pulmonary, Type 2 (SMDP2) approved 610913
Susceptibility to breast cancer due to a mutation in the c.7271T>G Ataxia-Telangiectasia Mutated (ATM) Gene approved *607585
Syndromic Microphthalmia 1 (MCOPS1) (Lenz syndrome) approved 309800
Syndromic Microphthalmia 12 (MCOPS12) approved 615524
Tay Sachs Disease (infantile onset) (TSD) approved 272800